Literature DB >> 16185245

Midbrain dopaminergic development in vivo and in vitro from embryonic stem cells.

Sarah L Maxwell1, Meng Li.   

Abstract

The midbrain dopaminergic (mDA) neurons play a key role in the function of a variety of brain systems, including motor control and reward pathways. This has led to much interest in these neurons as targets for intervention in human disorders such as Parkinson's disease and schizophrenia. A major area of interest is to direct embryonic stem (ES) cells to differentiate into mDA neurons in vitro, which can then be used for cell therapy or drug screening. At present, our understanding of mDA development in vivo is limited. However, recent studies have identified a number of regulatory factors that influence the development of mDA neurons in vivo. Such studies will not only increase our understanding of mDA development in vivo, they may also promote new paradigms for regulating mDA production from ES cells in vitro. Here we review the current knowledge on mDA development in vivo and mDA differentiation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16185245      PMCID: PMC1571533          DOI: 10.1111/j.1469-7580.2005.00453.x

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  59 in total

1.  CNS stem cells express a new class of intermediate filament protein.

Authors:  U Lendahl; L B Zimmerman; R D McKay
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

2.  Expression patterns of the homeo box-containing genes En-1 and En-2 and the proto-oncogene int-1 diverge during mouse development.

Authors:  C A Davis; A L Joyner
Journal:  Genes Dev       Date:  1988-12       Impact factor: 11.361

3.  Cellular expression of the immediate early transcription factors Nurr1 and NGFI-B suggests a gene regulatory role in several brain regions including the nigrostriatal dopamine system.

Authors:  R H Zetterström; R Williams; T Perlmann; L Olson
Journal:  Brain Res Mol Brain Res       Date:  1996-09-05

4.  Subtle cerebellar phenotype in mice homozygous for a targeted deletion of the En-2 homeobox.

Authors:  A L Joyner; K Herrup; B A Auerbach; C A Davis; J Rossant
Journal:  Science       Date:  1991-03-08       Impact factor: 47.728

5.  Establishment in culture of pluripotential cells from mouse embryos.

Authors:  M J Evans; M H Kaufman
Journal:  Nature       Date:  1981-07-09       Impact factor: 49.962

6.  The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain.

Authors:  A P McMahon; A Bradley
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

7.  The midbrain-hindbrain phenotype of Wnt-1-/Wnt-1- mice results from stepwise deletion of engrailed-expressing cells by 9.5 days postcoitum.

Authors:  A P McMahon; A L Joyner; A Bradley; J A McMahon
Journal:  Cell       Date:  1992-05-15       Impact factor: 41.582

8.  Target and neurotransmitter specificity of fetal central nervous system transplants: importance for functional reinnervation.

Authors:  J L Hudson; P Bickford; M Johansson; B J Hoffer; I Strömberg
Journal:  J Neurosci       Date:  1994-01       Impact factor: 6.167

9.  Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain.

Authors:  K Sakurada; M Ohshima-Sakurada; T D Palmer; F H Gage
Journal:  Development       Date:  1999-09       Impact factor: 6.868

10.  Multiple developmental defects in Engrailed-1 mutant mice: an early mid-hindbrain deletion and patterning defects in forelimbs and sternum.

Authors:  W Wurst; A B Auerbach; A L Joyner
Journal:  Development       Date:  1994-07       Impact factor: 6.868

View more
  8 in total

Review 1.  Toward a neurobiology of delusions.

Authors:  P R Corlett; J R Taylor; X-J Wang; P C Fletcher; J H Krystal
Journal:  Prog Neurobiol       Date:  2010-06-15       Impact factor: 11.685

2.  Acrolein-mediated alpha-synuclein pathology involvement in the early post-injury pathogenesis of mild blast-induced Parkinsonian neurodegeneration.

Authors:  Glen Acosta; Nicholas Race; Seth Herr; Joseph Fernandez; Jonathan Tang; Edmond Rogers; Riyi Shi
Journal:  Mol Cell Neurosci       Date:  2019-06-12       Impact factor: 4.314

Review 3.  Stem cell transplantation therapy for multifaceted therapeutic benefits after stroke.

Authors:  Ling Wei; Zheng Z Wei; Michael Qize Jiang; Osama Mohamad; Shan Ping Yu
Journal:  Prog Neurobiol       Date:  2017-03-18       Impact factor: 11.685

4.  Valproic acid enhances neuronal differentiation of sympathoadrenal progenitor cells.

Authors:  V Vukićević; N Qin; M Balyura; G Eisenhofer; M L Wong; J Licinio; S R Bornstein; M Ehrhart-Bornstein
Journal:  Mol Psychiatry       Date:  2015-02-24       Impact factor: 15.992

5.  Spatial and temporal lineage analysis of a Pitx3-driven Cre-recombinase knock-in mouse model.

Authors:  Marten P Smidt; Lars von Oerthel; Elisa J Hoekstra; Raymond D Schellevis; Marco F M Hoekman
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

Review 6.  Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques.

Authors:  Ginetta Collo; Armida Mucci; Giulia M Giordano; Emilio Merlo Pich; Silvana Galderisi
Journal:  Front Neurosci       Date:  2020-06-18       Impact factor: 4.677

Review 7.  Human embryonic stem cell differentiation toward regional specific neural precursors.

Authors:  Slaven Erceg; Mohammad Ronaghi; Miodrag Stojković
Journal:  Stem Cells       Date:  2009-01       Impact factor: 6.277

Review 8.  Immortalization of neuronal progenitors using SV40 large T antigen and differentiation towards dopaminergic neurons.

Authors:  A Alwin Prem Anand; S Gowri Sankar; V Kokila Vani
Journal:  J Cell Mol Med       Date:  2012-11       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.